Literature DB >> 9114044

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

H M Dansky1, S A Charlton, M M Harper, J D Smith.   

Abstract

Cellular and humoral immunity have been implicated in the pathogenesis of atherosclerosis. To determine whether an intact immune system is necessary for the formation of atherosclerotic lesions, we have generated immunodeficient mice with hypercholesterolemia and atherosclerosis by crossbreeding the apolipoprotein E (apoE)-deficient mouse with the recombinase activating gene 1 (Rag-1) knockout mouse. Chow-fed immunodeficient mice with targeted disruption in both apoE and Rag-1 (E0/R0) had a 2-fold decrement in aortic root lesion size at 16 weeks of age, compared with immunocompetent littermates, which were heterozygotes at the Rag-1 locus (E0/R1). Nearly all atherosclerotic lesions from chow-fed animals were limited to raised foam cell fatty streaks. In contrast, when a second group of animals was fed a high-fat Western-type diet to accelerate lesion development, there were no differences in either aortic root lesion size or the percent of the total aorta occupied by lesions. Fibrous plaques with well-defined caps and necrotic cores were detected in both Western diet-fed E0/R0 and E0/R1 animals. We conclude that T and B lymphocytes play only a minor role in the rate of forming foam cell lesions, and they are not necessary for the formation of fibroproliferative plaques.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114044      PMCID: PMC20777          DOI: 10.1073/pnas.94.9.4642

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.

Authors:  A I Fyfe; J H Qiao; A J Lusis
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

2.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

3.  Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

Authors:  A S Plump; C J Scott; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

4.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.

Authors:  W Palinski; E Miller; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

5.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.

Authors:  W Palinski; R K Tangirala; E Miller; S G Young; J L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

6.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

Authors:  J D Smith; E Trogan; M Ginsberg; C Grigaux; J Tian; M Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Authors:  S Stemme; B Faber; J Holm; O Wiklund; J L Witztum; G K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.

Authors:  S E Roselaar; G Schonfeld; A Daugherty
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.

Authors:  W Palinski; V A Ord; A S Plump; J L Breslow; D Steinberg; J L Witztum
Journal:  Arterioscler Thromb       Date:  1994-04

10.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Authors:  F Liao; A Andalibi; F C deBeer; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  87 in total

1.  Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?

Authors:  Joseph L Witztum
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 3.  How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.

Authors:  Jillian P Rhoads; Amy S Major
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 4.  Mechanisms that regulate macrophage burden in atherosclerosis.

Authors:  Gwendalyn J Randolph
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

5.  Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE-/- (Apolipoprotein E Deficient) Mice.

Authors:  Min Zhang; Xianqiu Zeng; Qiuhua Yang; Jiean Xu; Zhiping Liu; Yaqi Zhou; Yapeng Cao; Xiaoyu Zhang; Xiaofei An; Yiming Xu; Lei Huang; Zhen Han; Tao Wang; Chaodong Wu; David J Fulton; Neal L Weintraub; Mei Hong; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

6.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 7.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

8.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

Authors:  A Nicoletti; S Kaveri; G Caligiuri; J Bariéty; G K Hansson
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 9.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.